menu
    • menu

    Company profile for Senisca

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their...
    SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seniscaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    RILD Building Barrack Road Exeter EX2 5DW
    Telephone
    Telephone
    +44 (0) 7515 454 146
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.senisca.com/
    Linkedin
    Linkedin
    https://uk.linkedin.com/company/senisca
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SENISCA appoints Tim Edwards as Chair of the Board
    SENISCA appoints Tim Edwards as Chair of the Board

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943371/0/en/SENISCA-appoints-Tim-Edwards-as-Chair-of-the-Board.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    SENISCA secures additional £3.7 to support the senotherapeutic platform
    SENISCA secures additional £3.7 to support the senotherapeutic platform

    18 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/18/2847464/0/en/SENISCA-secures-additional-3-7-million-financing-to-support-rapid-development-of-senotherapeutic-platform-to-treat-age-related-disease.html

    GLOBENEWSWIRE
    18 Mar 2024
    Share Share
    SENISCA appoints Dr. Sarah Cole as Chief Executive Officer
    SENISCA appoints Dr. Sarah Cole as Chief Executive Officer

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2771906/0/en/SENISCA-appoints-Dr-Sarah-Cole-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    SENISCA shortlisted for 2022/2023 Nature Spinoff prize
    SENISCA shortlisted for 2022/2023 Nature Spinoff prize

    25 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/25/2675836/0/en/SENISCA-shortlisted-for-2022-2023-Nature-Spinoff-prize.html

    GLOBENEWSWIRE
    25 May 2023
    Share Share
    SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics
    SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics

    20 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/20/2650670/0/en/SENISCA-awarded-Innovate-UK-grant-to-develop-oligonucleotide-therapeutics-for-the-treatment-of-idiopathic-pulmonary-fibrosis-IPF.html

    GLOBENEWSWIRE
    20 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search